Literature DB >> 26769137

Cholangiocarcinoma with intraductal tubular growth pattern versus intraductal papillary growth pattern.

Tetsuo Tsukahara1, Yoshie Shimoyama2, Tomoki Ebata1, Yukihiro Yokoyama1, Tsuyoshi Igami1, Gen Sugawara1, Takashi Mizuno1, Junpei Yamaguchi1, Shigeo Nakamura2, Masato Nagino1.   

Abstract

Intraductal neoplasms of the bile duct are macroscopically characterized by exophytic or polypoid growth patterns and have a favorable prognosis. Although some tumors with a predominantly tubular microscopic pattern have been reported, they have not been well characterized clinicopathologically. The purpose of the present study was to compare the newly recognized cholangiocarcinoma with an intraductal tubular growth pattern and cholangiocarcinoma with an intraductal papillary growth pattern and to investigate the pathological and prognostic significance of the former. This study analyzed 161 patients with tumors with exophytic or polypoid growth patterns from a large series of 733 cholangiocarcinoma cases surgically resected from January 1998 to May 2013. The study patients were divided into two groups: those whose tumors showed a predominantly tubular growth pattern (n=52) and those whose tumors exhibited a predominantly papillary growth pattern (n=109). Tubular growth pattern was associated with combined vascular resection and the absence of macroscopic mucin. Several histological indexes were significantly higher for the tubular growth pattern than the papillary one, including tubular adenocarcinoma, depth of invasion, microscopic lymphatic invasion, venous invasion, perineural invasion, and necrosis. Although the survival curves overlapped (P=0.693), the rate of liver metastasis was significantly higher for the tubular growth pattern than for the papillary one (P=0.012). Genomic DNA analysis focusing on somatic mutations in codons 12 and 13 of KRAS and codon 600 of BRAF revealed only one (4%) KRAS and no BRAF mutation among the 25 tubular cases examined. In conclusion, the tubular growth pattern exhibited differences in some histologic indexes, in addition to a higher hepatic metastasis rate and a lower KRAS mutation frequency, compared with the papillary growth pattern, but no difference in prognosis was observed. The distinctiveness of this tubular neoplasm should be further examined in the future.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26769137     DOI: 10.1038/modpathol.2015.152

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  37 in total

1.  Noninvasive and minimally invasive papillary carcinomas of the extrahepatic bile ducts.

Authors:  J Albores-Saavedra; L Murakata; J E Krueger; D E Henson
Journal:  Cancer       Date:  2000-08-01       Impact factor: 6.860

2.  Mucinous cystic neoplasms of the liver: a clinicopathological study and comparison with intraductal papillary neoplasms of the bile duct.

Authors:  Yoh Zen; Federica Pedica; Venkata R Patcha; Paola Capelli; Giuseppe Zamboni; Andrea Casaril; Alberto Quaglia; Yasuni Nakanuma; Nigel Heaton; Bernard Portmann
Journal:  Mod Pathol       Date:  2011-04-22       Impact factor: 7.842

3.  Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases of hepatolithiasis.

Authors:  Yoh Zen; Motoko Sasaki; Takahiko Fujii; Tse-Ching Chen; Miin-Fu Chen; Ta-Sen Yeh; Yi-Yin Jan; Shiu-Feng Huang; Yuji Nimura; Yasuni Nakanuma
Journal:  J Hepatol       Date:  2005-12-05       Impact factor: 25.083

4.  Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion.

Authors:  Masayuki Ohtsuka; Fumio Kimura; Hiroaki Shimizu; Hiroyuki Yoshidome; Atsushi Kato; Hideyuki Yoshitomi; Katsunori Furukawa; Dan Takeuchi; Tsukasa Takayashiki; Kosuke Suda; Shigetsugu Takano; Yoichiro Kondo; Masaru Miyazaki
Journal:  Am J Surg Pathol       Date:  2011-04       Impact factor: 6.394

5.  Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria.

Authors:  Yoh Zen; N Volkan Adsay; Krystof Bardadin; Romano Colombari; Linda Ferrell; Hironori Haga; Seung-Mo Hong; Prodromos Hytiroglou; Günter Klöppel; Gregory Y Lauwers; Dirk J van Leeuwen; Kenji Notohara; Kiyoko Oshima; Alberto Quaglia; Motoko Sasaki; Fausto Sessa; Arief Suriawinata; Wilson Tsui; Yutaka Atomi; Yasuni Nakanuma
Journal:  Mod Pathol       Date:  2007-04-13       Impact factor: 7.842

6.  Intraductal papillary neoplasia of the liver associated with hepatolithiasis.

Authors:  T C Chen; Y Nakanuma; Y Zen; M F Chen; Y Y Jan; T S Yeh; C T Chiu; T T Kuo; J Kamiya; K Oda; M Hamaguchi; Y Ohno; L L Hsieh; Y Nimura
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

Review 7.  Intrahepatic cholangiocarcinoma: macroscopic type and stage classification.

Authors:  Susumu Yamasaki
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

8.  KRAS and GNAS mutations and p53 overexpression in biliary intraepithelial neoplasia and intrahepatic cholangiocarcinomas.

Authors:  Maylee Hsu; Motoko Sasaki; Saya Igarashi; Yasunori Sato; Yasuni Nakanuma
Journal:  Cancer       Date:  2013-01-18       Impact factor: 6.860

9.  Perineural invasion is a prognostic factor in intrahepatic cholangiocarcinoma.

Authors:  Kazuhisa Shirai; Tomoki Ebata; Koji Oda; Hideki Nishio; Tetsuro Nagasaka; Yuji Nimura; Masato Nagino
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

10.  Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions.

Authors:  Jesse S Voss; Leonard M Holtegaard; Sarah E Kerr; Emily G Barr Fritcher; Lewis R Roberts; Gregory J Gores; Jun Zhang; W Edward Highsmith; Kevin C Halling; Benjamin R Kipp
Journal:  Hum Pathol       Date:  2013-02-04       Impact factor: 3.526

View more
  4 in total

Review 1.  Treatment of Malignant Bile Duct Obstruction: What the Interventional Radiologist Needs to Know.

Authors:  Juan C Camacho; Lynn A Brody; Anne M Covey
Journal:  Semin Intervent Radiol       Date:  2021-08-10       Impact factor: 1.780

Review 2.  Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression.

Authors:  Alphonse E Sirica; Mario Strazzabosco; Massimiliano Cadamuro
Journal:  Adv Cancer Res       Date:  2020-12-09       Impact factor: 6.242

3.  Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosis.

Authors:  Chanitra Thuwajit; Peti Thuwajit; Pranisa Jamjantra; Chawalit Pairojkul; Sopit Wongkham; Vajarabhongsa Bhudhisawasdi; Junya Ono; Shoichiro Ohta; Kiminori Fujimoto; Kenji Izuhara
Journal:  Oncol Lett       Date:  2017-05-25       Impact factor: 2.967

Review 4.  Moving forward in the treatment of cholangiocarcinoma.

Authors:  Tommaso M Manzia; Alessandro Parente; Ilaria Lenci; Bruno Sensi; Martina Milana; Carlo Gazia; Alessandro Signorello; Roberta Angelico; Giuseppe Grassi; Giuseppe Tisone; Leonardo Baiocchi
Journal:  World J Gastrointest Oncol       Date:  2021-12-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.